Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study

Ultrasound in Obstetrics and Gynecology

Volumn 49, Issue 5, 2017, Pages 599-606

  Bakker, M ^a   Birnie, E ^a   Robles de Medina, P ^b   Sollie, K M ^a   Pajkrt, E ^b   Bilardo, C M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

amniocentesis; chorionic villus sampling; fetal loss; first trimester; prenatal diagnosis

Indexed keywords

ADULT; ADVERSE EFFECTS; AMNIOCENTESIS; CHORION VILLUS SAMPLING; CLINICAL COMPETENCE; CLINICAL TRIAL; COHORT ANALYSIS; EPIDEMIOLOGY; FACTUAL DATABASE; FEMALE; FETUS DEATH; HUMAN; MULTICENTER STUDY; NETHERLANDS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; STILLBIRTH;

ADULT; AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; CLINICAL COMPETENCE; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FETAL DEATH; HUMANS; NETHERLANDS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; STILLBIRTH;

EID: 85018957569     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.15986     Document Type: Article

References (33)

1. Bakker M, Birnie E, Pajkrt E, Bilardo CM, Snijders RJ. Low uptake of the combined test in The Netherlands – which factors contribute? Prenat Diagn 2012; 32: 1305–1312.
2. Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Dar P, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; FaSTER Trial Research Consortium. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol 2008; 199: 290.e1–290.e6.
3. Papantoniou NE, Daskalakis GJ, Tziotis JG, Kitmirides SJ, Mesogitis SA, Antsaklis AJ. Risk factors predisposing to fetal loss following a second trimester amniocentesis. BJOG 2001; 108: 1053–1056.
4. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010; 27: 1–7.
5. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 45, 16–26.
6. Young C, von Dadelszen P, Alfirevic Z. Instruments for chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2013; CD000114.
7. Wijnberger LD, van der Schouw YT, Christiaens GC. Learning in medicine: chorionic villus sampling. Prenat Diagn 2000; 20: 241–246.
8. Tabor A, Vestergaard CH, Lidegaard O. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009; 34: 19–24.
9. Akolekar R, Bower S, Flack N, Bilardo CM, Nicolaides KH. Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus sampling. Prenat Diagn 2011; 31: 38–45.
10. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 327: 1287–1293.
11. Smidt-Jensen S, Permin M, Philip J, Lundsteen C, Zachary JM, Fowler SE, Gruning K. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet 1992; 340: 1237–1244.
12. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Lancet 1989; 333: 1–6.
13. Giorlandino C, Cignini P, Cini M, Brizzi C, Carcioppolo O, Milite V, Coco C, Gentili P, Mangiafico L, Mesoraca A, Bizzoco D, Gabrielli I, Mobili L. Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial. Prenat Diagn 2009; 29: 606–612.
14. Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006; 108: 612–616.
15. Centini G, Rosignoli L, Kenanidis A, Scarinci R, Petraglia F. A report of early (13 + 0 to 14 + 6 weeks) and mid-trimester amniocenteses: 10 years' experience. J Matern Fetal Neonatal Med 2003; 14: 113–117.
16. Corrado F, Cannata ML, La Galia T, Magliarditi M, Imbruglia L, D'anna R, Carlo Stella N. Pregnancy outcome following mid-trimester amniocentesis. J Obstet Gynaecol 2012; 32: 117–119.
17. Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Porter TF, Luthy DA, Comstock CH, Saade GR, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006; 108: 1067–1072.
18. Odibo AO, Dicke JM, Gray DL, Oberle B, Stamilio DM, Macones GA, Crane JP. Evaluating the rate and risk factors for fetal loss after chorionic villus sampling. Obstet Gynecol 2008; 112: 813–819.
19. Pitukkijronnakorn S, Promsonthi P, Panburana P, Udomsubpayakul U, Chittacharoen A. Fetal loss associated with second trimester amniocentesis. Arch Gynecol Obstet 2011; 284: 793–797.
20. Towner D, Currier RJ, Lorey FW, Cunningham GC, Greve LC. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening. Am J Obstet Gynecol 2007; 196: 608.e1–608.e5; discussion 608.e5.
21. Lau KT, Leung YT, Fung YT, Chan LW, Sahota DS, Leung NT. Outcome of 1,355 consecutive transabdominal chorionic villus samplings in 1,351 patients. Chin Med J (Engl) 2005; 118: 1675–1681.
22. Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Reply. Ultrasound Obstet Gynecol 2015; 45: 755–757.
23. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110: 687–694.
24. Roper EC, Konje JC, De Chazal RC, Duckett DP, Oppenheimer CA, Taylor DJ. Genetic amniocentesis: gestation-specific pregnancy outcome and comparison of outcome following early and traditional amniocentesis. Prenat Diagn 1999; 19: 803–807.
25. Cohen-Overbeek TE, Hop WC, den Ouden M, Pijpers L, Jahoda MG, Wladimiroff JW. Spontaneous abortion rate and advanced maternal age: consequences for prenatal diagnosis. Lancet 1990; 336: 27–29.
26. Nanal R, Kyle P, Soothill PW. A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix. Prenat Diagn 2003; 23: 488–492.
27. Ghidini A. Re: Risk of miscarriage following amniocentesis and chorionic villus sampling. Ultrasound Obstet Gynecol 2015; 45: 755.
28. Chueh JT, Goldberg JD, Wohlferd MM, Golbus MS. Comparison of transcervical and transabdominal chorionic villus sampling loss rates in nine thousand cases from a single center. Am J Obstet Gynecol 1995; 173: 1277–1282.
29. Wulff CB, Gerds TA, Rode L, Ekelund CK, Petersen OB, Tabor A; Danish Fetal Medicine Study Group. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies. Ultrasound Obstet Gynecol 2016; 47: 38–44.
30. Ville Y, Cooper M, Revel A, Frydman R, Nicolaides KH. Development of a training model for ultrasound-guided invasive procedures in fetal medicine. Ultrasound Obstet Gynecol 1995; 5: 180–183.
31. Silver RK, Russell TL, Kambich MP, Leeth EA, MacGregor SN, Sholl JS. Midtrimester amniocentesis. Influence of operator caseload on sampling efficiency. J Reprod Med 1998; 43: 191–195.
32. Alfirevic Z. Who should be allowed to perform amniocentesis and chorionic villus sampling? Ultrasound Obstet Gynecol 2009; 34: 12–13.
33. Ghi T, Sotiriadis A, Calda P, Da Silva Costa F, Raine-Fenning N, Alfirevic Z, McGillivray G; International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis. Ultrasound Obstet Gynecol 2016; 48: 256–268.